Life Science

LEO Pharma Expands Presence in Boston


Her Royal Highness, Crown Princess Mary of Denmark; and LEO Pharma president and CEO, Gitte Pugholm Aabo at the opening

Boston – LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin, recently inaugurated the LEO Science & Tech Hub in Boston by Her Royal Highness, Crown Princess Mary of Denmark. The event brought together members of the Boston life sciences community to explore opportunities for partnership and innovation with LEO Pharma.

The Hub aims to catalyze early-stage collaborations in science and technology in order to advance the treatment of skin diseases and is the first of its kind to focus on dermatology in the Greater Boston area, the world’s leading life sciences cluster.

It will build early-stage collaborations with academic centers, entrepreneurs, and companies in the United States, and support collaborators in validating novel targets in skin diseases and advancing technology towards commercialization.

The LEO Science & Tech Hub is located in the heart of the Kendall Square innovation district at the CIC in Cambridge.

“By offering our collaborators access to funding and a unique global network of dermatology expertise, we want to act as catalysts for innovation and help bring new science and technology to the next stage,” says Michael Sierra, vice president, LEO Science & Tech Hub.